Toxic epidermal necrolysis due to voriconazole: case report and review
Authors:
Open Access
- 1 January 2014
- journal article
- case report
- Published by California Digital Library (CDL) in Dermatology Online Journal
- Vol. 20 (9)
Abstract
Toxic epidermal necrolysis is an uncommon but potentially life-threatening adverse cutaneous drug reaction characterized by variable degrees of epidermal necrosis and detachment leading to morbidity and risk of mortality. We describe a 67-year-old woman who underwent allogeneic peripheral blood stem cell transplantation as treatment for chronic lymphocytic leukemia. She developed toxic epidermal necrolysis after she was transitioned to voriconazole, which was a component of her post-transplant regimen. The diagnosis of toxic epidermal necrolysis in our patient was made clinically and confirmed histologically. Based on the temporal initiation of voriconazole therapy and the development of her adverse cutaneous reaction, we concluded that voriconazole was the offending agent. There are limited reported cases of voriconazole-induced toxic epidermal necrolysis; we report this case to increase awareness of this potential life-threatening complication.Keywords
This publication has 13 references indexed in Scilit:
- The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysisBritish Journal of Dermatology, 2012
- IVIg in TEN: time to re-evaluate the efficacy of intravenous immunoglobulin in the management of toxic epidermal necrolysisBritish Journal of Dermatology, 2012
- Toxic epidermal necrolysis: Review of pathogenesis and managementJournal of the American Academy of Dermatology, 2012
- Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrumDermatologic Therapy, 2009
- Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-StudyJournal of Investigative Dermatology, 2008
- Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapyAnnals of Oncology, 2006
- Uncovering Histologic Criteria With Prognostic Significance in Toxic Epidermal NecrolysisArchives of Dermatology, 2005
- Toxic Epidermal Necrolysis as a Complication of Treatment with VoriconazoleSouthern Medical Journal, 2004
- Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal NecrolysisArchives of Dermatology, 2002
- Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema MultiformeArchives of Dermatology, 1993